131 related articles for article (PubMed ID: 9844478)
1. [Prevention and treatment of infections in patients with neutropenia and fever: the role of Pseudomonas aeruginosa].
Jiménez Martínez C; Ribera Santasusana JM; Giménez Pérez M; Batlle Masana M; Flores López A; Fernández-Avilés F; Sancho Cía JM; Millá Santos F; Feliu Frasnedo E
Rev Clin Esp; 1998 Sep; 198 Suppl 2():44-50. PubMed ID: 9844478
[No Abstract] [Full Text] [Related]
2. Pseudomonas aeruginosa infection in cystic fibrosis: prevent, eradicate or both?
Eber E; Zach MS
Thorax; 2010 Oct; 65(10):849-51. PubMed ID: 20861286
[No Abstract] [Full Text] [Related]
3. Antimicrobial prophylaxis in febrile neutropenia.
Yoshida M; Ohno R
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S65-7. PubMed ID: 15250025
[TBL] [Abstract][Full Text] [Related]
4. [Neutropenia and opportunistic infection].
Ono Y
Nihon Rinsho; 2003 Mar; 61 Suppl 3():127-33. PubMed ID: 12717959
[No Abstract] [Full Text] [Related]
5. Antibacterial prophylaxis in patients with cancer and neutropenia.
Almyroudis NG; Segal BH
N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395832
[No Abstract] [Full Text] [Related]
6. Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary.
Masaoka T
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S49-52. PubMed ID: 15250021
[No Abstract] [Full Text] [Related]
7. Unusual presentation of pseudomonas infection.
Weinbren MJ; Forgeson G; Helenglass G; Jameson B; Powles R
BMJ; 1988 Oct; 297(6655):1034-5. PubMed ID: 3142602
[No Abstract] [Full Text] [Related]
8. Prophylactic antibiotics in cystic fibrosis: a conviction without evidence?
Smyth A
Pediatr Pulmonol; 2005 Dec; 40(6):471-6. PubMed ID: 16200640
[TBL] [Abstract][Full Text] [Related]
9. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens.
Ramphal R
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S25-31. PubMed ID: 15250017
[TBL] [Abstract][Full Text] [Related]
10. Synthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa.
Cachia PJ; Hodges RS
Biopolymers; 2003; 71(2):141-68. PubMed ID: 12767116
[TBL] [Abstract][Full Text] [Related]
11. Treatment of patients with hematologic neoplasm, fever, and neutropenia.
Sepkowitz KA
Clin Infect Dis; 2005 Apr; 40 Suppl 4():S253-6. PubMed ID: 15768331
[TBL] [Abstract][Full Text] [Related]
12. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR
Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231
[TBL] [Abstract][Full Text] [Related]
13. Antibiotics in 30 minutes or less for febrile neutropenic patients: a quality control measure in a new hospital.
Corey AL; Snyder S
J Pediatr Oncol Nurs; 2008; 25(4):208-12. PubMed ID: 18539908
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial prophylaxis in patients with cancer and neutropenia.
Pasqualotto AC; Rosa DD; Machado AL
N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395830
[No Abstract] [Full Text] [Related]
15. Economic issues: toward a cost-effective approach to the management of febrile neutropenia in Japan.
Masaoka T
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S68-9. PubMed ID: 15250026
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients.
Mullen CA
Pediatr Infect Dis J; 2003 Dec; 22(12):1138-42. PubMed ID: 14688588
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa pneumonia as a presenting entity in an AIDS patient.
Kowal-Vern A; McFadden J
Clin Pediatr (Phila); 1989 Sep; 28(9):403. PubMed ID: 2504528
[No Abstract] [Full Text] [Related]
18. Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli.
Gomez L; Garau J; Estrada C; Marquez M; Dalmau D; Xercavins M; Martí JM; Estany C
Cancer; 2003 Jan; 97(2):419-24. PubMed ID: 12518366
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial prophylaxis in patients with cancer and neutropenia.
Castagna L; Santoro A
N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395831
[No Abstract] [Full Text] [Related]
20. Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study.
El-Mahallawy H; Sidhom I; El-Din NH; Zamzam M; El-Lamie MM
Int J Infect Dis; 2005 Jan; 9(1):43-51. PubMed ID: 15603994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
